Evaluation of Corneal and Tear Film Changes via Anterior Segment Optical Coherence Tomography Following Systemic Isotretinoin Therapy in Patients with Acne Vulgaris - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluation of Corneal and Tear Film Changes via Anterior Segment Optical Coherence Tomography Following Systemic Isotretinoin Therapy in Patients with Acne Vulgaris

  • By

  • Mohamed Salah El-Din Mahmoud

  • Hosny Ahmed Zein

  • Mustafa Mohamed Al-Anwar

  • Ahmed Maher Khalafallah

  • November 19, 2025

Share

Clinical Scorecard: Evaluation of Corneal and Tear Film Changes via Anterior Segment Optical Coherence Tomography Following Systemic Isotretinoin Therapy in Patients with Acne Vulgaris

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients aged 18 and older with severe cystic acne vulgaris unresponsive to other treatments, specifically detailing the severity.
Care Setting

Key Highlights

  • Add a highlight on the importance of monitoring ocular health during treatment.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • C
      • o
      • n
      • d
      • u
      • c
      • t
      • r
      • e
      • g
      • u
      • l
      • a
      • r
      • a
      • s
      • s
      • e
      • s
      • s
      • m
      • e
      • n
      • t
      • s
      • o
      • f
      • t
      • e
      • a
      • r
      • f
      • i
      • l
      • m
      • a
      • n
      • d
      • c
      • o
      • r
      • n
      • e
      • a
      • l
      • t
      • h
      • i
      • c
      • k
      • n
      • e
      • s
      • s
      • u
      • s
      • i
      • n
      • g
      • A
      • S
      • -
      • O
      • C
      • T
      • ,
      • w
      • i
      • t
      • h
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • f
      • o
      • l
      • l
      • o
      • w
      • -
      • u
      • p
      • i
      • n
      • t
      • e
      • r
      • v
      • a
      • l
      • s
      • .

      Risks

        Patient & Prescribing Data

        Isotretinoin dosage of 0.8 mg/kg daily is effective but requires monitoring for ocular side effects, with a specified treatment duration.

        Clinical Best Practices

        • Include patient education on recognizing ocular side effects.

        Related Resources & Content

        Original Source(s)

        Related Content